Change in 21-gene Recurrence Score result after exposure to neo-adjuvant endocrine therapy in patients with operable breast cancer.

Clicks: 331
ID: 84190
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #4 of 5 articles by views in the breast journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
hilal2019changethe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hilal, Talal;Mi, Lanyu;Ertz-Archambault, Natalie M;Almquist, Daniel R;Anderson, Karen S;Gray, Richard J;Pockaj, Barbara A;Northfelt, Donald W;
Journal the breast journal
Year 2019
DOI
10.1111/tbj.13731
URL
Keywords
MCF-7 mtor gsk1059615. glucose restriction mda-mb 231 pkm2

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.